Drugs / White Blood Cells/Granulocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00900497 | Apr 2009 → Dec 2029 expected | cancer | Dipnarine Maharaj | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | White Blood Cells/Granulocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00900497 ↗ |
| Modality | Cell therapy | “The infusion of white blood cells, particularly cells of innate immunity, is a viable anticancer therapy in humans as well.” NCT00900497 ↗ |